Green Cross to supply flu vaccine for $12 million

Published: 2012-12-27 06:57:00

Updated: 2012-12-27 06:57:00

Green Cross Corp., a Korean drug maker, said Monday it has won the order placed by the Pan American Health Organization (PAHO), a regional WHO body, to supply its influenza vaccines, worth $12 million, to South America.

Last month, Green Cross obtained a prequalification approval from the Worl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK